Treatment
Treatment clinical trials
We’re tracking 8,310 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT06730386RecruitingPhase 1
Trial of AK138D1 for advanced solid tumors
This trial tests a new drug called AK138D1 for people with advanced solid tumors that have not responded to or can't tolerate standard treatments. The goal is to see if it is safe and effective.
Blacktown, New South WalesAges 18–75 - NCT06778031RecruitingPhase 2
Study of SHR-A1811 for HER2-positive bile duct cancer
This trial tests a new drug, SHR-A1811, for people with HER2-positive bile duct cancer that has spread or cannot be removed by surgery. It may help control the cancer if you haven't had other treatments for this stage.
Harbin, HeilongjiangAges 18–75 - NCT06862934Recruiting
Liver transplant for bile duct cancer that can't be removed
This study tests if a liver transplant can help people with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. It is for patients whose cancer has been stable for at least 6 months after initial treatments.
Milan, MilanAges 18–70 - NCT05190718Recruiting
Pharyngeal electrical stimulation for swallowing trouble after brain injury
This trial tests a non-drug therapy that uses gentle electrical stimulation to help people swallow safely when swallowing is affected by certain brain or nerve conditions. If you qualify, you may receive this approach to improve swallowing and reduce choking risk.
Tulln, Low AustriaAges 18 years+ - NCT04178434Recruiting
Online therapy for stress and anxiety after heart pain without blockages
This trial studies whether an internet-based therapy program can reduce stress and anxiety in people who may have heart-related conditions like MINOCA or takotsubo syndrome, but without significant coronary artery blockages. If you fit the mood and heart criteria, the program may help you feel calmer and improve day-to-day wellbeing.
StockholmAges 35–79 - NCT04956133Recruiting
Physical activity program for kids during cancer treatment
This trial tests whether a structured physical activity program can help children and teens feel better and stay active during cancer treatment or shortly after. It involves the child and a parent/caregiver for safety during sessions.
Calgary, AlbertaAges 5–18 - NCT05782010Recruiting
Testing a hemorrhoid device for grade II or III hemorrhoids
This study tests how safe and well a hemorrhoid treatment device (PexyEazy®) works for adults with moderate-to-severe hemorrhoids (grade II–III). You may be a candidate if you fit the hemorrhoid grade and medical safety requirements and can follow the study plan.
FrölundaAges 18–84 - NCT05918328RecruitingPhase 2
Testing two medicines before surgery for HER2-positive breast cancer
This Phase 2 trial compares nab-PH plus pyrrolitinib versus TCbHP as treatment given before breast surgery. It aims to see which option works better and is safe for people with HER2-positive invasive breast cancer.
Zhengzhou, HenanAges 18–65 - NCT06601127RecruitingPhase 2
Tiprogrel for recent minor stroke or high-risk TIA
This trial tests a new anti-platelet drug called Tiprogrel to prevent another stroke in people who recently had a minor stroke or a transient ischemic attack (TIA) with certain artery narrowing or plaques. It aims to see if this medicine is safe and works better than current treatments.
Shenyang, LiaoningAges 40 years+ - NCT07329712Recruiting
Light therapy for dry eye: tear protein study
This trial tests whether low-level light therapy can improve dry eye disease by measuring changes in tear proteins. It may help people with chronic dry eye who are interested in a non-drug treatment.
SingaporeAges 21 years+ - NCT07326995RecruitingPhase 2
Inhaled PA9159 for Adults with Moderate Asthma
This trial tests a new inhaled medicine called PA9159 for adults with moderate asthma. It compares the medicine to a placebo to see if it safely improves breathing and controls asthma symptoms.
Nanchang, JiangxiAges 18–75 - NCT07329777RecruitingPhase 3
Atropine eye drops for children with worsening nearsightedness
This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.
Kuala Lumpur, CherasAges 5–10 - NCT07326657Enrolling by invitationPhase 4
Fish skin graft for deep partial-thickness burns
This trial tests if a fish skin graft can help heal deep burns and reduce the need for a skin graft from your own body. It compares the fish skin graft to standard care for burns on the torso or arms and legs.
Maywood, IllinoisAges 18 years+ - NCT07331181Recruiting
Studying a treatment for cheek and décolletage wrinkles
This trial tests two treatments called INNEA and INNEA AQUA for cheek and décolletage wrinkles. The goal is to see how well they work and if they are safe for women aged 35-65.
Brescia, BresciaAges 35–65 - NCT07325097RecruitingPhase 1
Corneal implant for swelling of the cornea
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
YerevanAges 18 years+ - NCT07326813RecruitingPhase 3
Testing D-2570 for moderate to severe plaque psoriasis
This trial tests if a new oral medication called D-2570 can safely and effectively treat moderate to severe plaque psoriasis. It may be an option if your psoriasis covers a large area and has been stable for at least 6 months.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07333118RecruitingEarly Phase 1
Testing GT801 for severe autoimmune diseases
This trial tests a new treatment called GT801, a type of CAR-T cell therapy, for people with moderate to severe autoimmune diseases that have not responded to standard treatments. It aims to see if GT801 can safely and effectively control the disease.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07332182Recruiting
MaioRegen scaffold for deep knee cartilage injuries
This study tests a special scaffold (MaioRegen Prime) that helps regrow cartilage and bone in deep knee injuries. It is for people who have not gotten better with physical therapy and need a repair option.
La Mesa, CaliforniaAges 18–60 - NCT07329322RecruitingPhase 2
Drug combo before surgery for EGFR-mutated lung cancer
This trial tests a combination of two targeted drugs (sacituzumab tirumotecan and osimertinib) before surgery for people with a specific type of lung cancer (EGFR-mutated). The goal is to see if the drugs can shrink the tumor enough to improve surgery results.
BeijingAges 18–75 - NCT06864130RecruitingPhase 4
Stopping Alendronate in osteoporosis after no fractures
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
AalborgAges Any age - NCT07325305Recruiting
Exercise to protect muscle in childhood leukemia
This trial tests whether starting physical activity and exercise early in treatment can help children with leukemia prevent muscle loss and reduce frailty. It involves wearing a Fitbit to track activity and may help kids stay stronger during and after treatment.
Melbourne, VictoriaAges 5–17 - NCT07330544RecruitingPhase 2
Study of entinostat with anlotinib or fulvestrant for advanced breast cancer
This trial tests adding entinostat (a drug that may help hormone therapy work better) to anlotinib or fulvestrant for people with HR-positive, HER2-negative advanced breast cancer that has worsened after prior hormone therapy and a CDK4/6 inhibitor. It aims to find a new treatment option for those who cannot use chemotherapy yet.
Zhejiang, HangzhouAges 18 years+ - NCT07330063RecruitingPhase 2
Pain relief injection after laparoscopic stomach cancer surgery
This trial tests an injection called Anrikefon to see if it can safely and effectively reduce pain after surgery to remove part of the stomach for cancer. The surgery is done through small cuts (laparoscopic), and this treatment is given after surgery to help with pain while you recover.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07328230Recruiting
New procedure vs standard pill for adrenal-related high blood pressure
This study tests if a new procedure (blocking tiny adrenal arteries) works as well as a standard pill (spironolactone) for lowering high blood pressure caused by too much aldosterone from both adrenal glands. It is designed for people whose high blood pressure is due to idiopathic hyperaldosteronism.
Beijing, Beijing MunicipalityAges 15–60
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.